Implementation of advanced technologies in commercial monoclonal antibody production

Process advancements driven through innovations have been key factors that enabled successful commercialization of several human therapeutic antibodies in recent years. The production costs of these molecules are higher in comparison to traditional medicines. In order to lower the development and later manufacturing costs, recent advances in antibody production technologies target higher throughput processes with increased clinical and commercial economics. In this review, essential considerations and trends for commercial process development and optimization are described, followed by the challenges to obtain a high titer cell culture process and its subsequent impact on the purification process. One of these recent technical advances is the development and implementation of a disposable Q membrane adsorber as an alternative to a Q‐packed‐bed column in a flow‐through mode. The scientific concept and principles underlining Q membrane technology and its application are also reviewed.

[1]  Dirk Weuster-Botz,et al.  Parallel reactor systems for bioprocess development. , 2005, Advances in biochemical engineering/biotechnology.

[2]  Y. Akselband,et al.  Transfected Cell Line Enrichment Using the Gel Microdrop (GMD) Secretion Assay , 2003 .

[3]  Kurt Brorson,et al.  Impact of multiple re-use of anion-exchange chromatography media on virus removal. , 2005, Journal of chromatography. A.

[4]  Thomas Ryll,et al.  Effects of temperature shift on cell cycle, apoptosis and nucleotide pools in CHO cell batch cultues , 2004, Cytotechnology.

[5]  Sanchayita Ghose,et al.  Evaluation and comparison of alternatives to Protein A chromatography Mimetic and hydrophobic charge induction chromatographic stationary phases. , 2006, Journal of chromatography. A.

[6]  A. Zydney,et al.  Effect of solution pH on protein transmission and membrane capacity during virus filtration , 2008, Biotechnology and bioengineering.

[7]  M. Al-Rubeai,et al.  Improved cell line development by a high throughput affinity capture surface display technique to select for high secretors. , 1999, Journal of immunological methods.

[8]  S. Cramer,et al.  Membrane chromatographic systems for high-throughput protein separations , 1992 .

[9]  D. Keith Roper,et al.  Separation of biomolecules using adsorptive membranes , 1995 .

[10]  R. Freitag,et al.  Characterization and application of strong ion-exchange membrane adsorbers as stationary phases in high-performance liquid chromatography of proteins. , 1993, Journal of chromatography. A.

[11]  F. Steindl,et al.  Scaleup of monoclonal antibody purification using radial streaming ion exchange chromatography , 1988, Biotechnology and bioengineering.

[12]  Xudong Ge,et al.  Validation of an optical sensor-based high-throughput bioreactor system for mammalian cell culture. , 2006, Journal of biotechnology.

[13]  Joe X. Zhou,et al.  Basic Concepts in Q Membrane Chromatography for Large‐Scale Antibody Production , 2006, Biotechnology progress.

[14]  G A Keller,et al.  Endogenous origin of defective retroviruslike particles from a recombinant Chinese hamster ovary cell line. , 1991, Virology.

[15]  D. Lütkemeyer,et al.  Membrane chromatography for rapid purification of recombinant antithrombin III and monoclonal antibodies from cell culture supernatant. , 1993, Journal of chromatography.

[16]  Arthur Daemmrich,et al.  A rising drug industry , 2005 .

[17]  F. Švec,et al.  High-performance membrane chromatography: Highly efficient separation method for proteins in ion-exchange, hydrophobic interaction and reversed-phase modes , 1993 .

[18]  Daniel J. Klingenberg,et al.  Flow distribution in chromatographic columns , 1999 .

[19]  D. L. Cole,et al.  Large-scale purification of antisense oligonucleotides by high-performance membrane adsorber chromatography. , 2000, Journal of chromatography. A.

[20]  Nigel Jenkins,et al.  Getting the glycosylation right: Implications for the biotechnology industry , 1996, Nature Biotechnology.

[21]  M. Kula,et al.  Fast protein chromatography on analytical and preparative scale using modified microporous membranes , 1992 .

[22]  M. Kula,et al.  Application of thiophilic membranes for the purification of monoclonal antibodies from cell culture media. , 1995, Journal of chromatography. B, Biomedical applications.

[23]  Joe X. Zhou,et al.  Non-specific binding and saturation of Polysorbate-20 with aseptic filter membranes for drug substance and drug product during mAb production , 2008 .

[24]  S. Chamow,et al.  Therapeutic antibody expression technology. , 2001, Current opinion in biotechnology.

[25]  S. Zale,et al.  Membrane-Based Affinity Technology for Commercial Scale Purifications , 1988, Bio/Technology.

[26]  M. Etzel,et al.  Analysis of Protein Purification Using Ion-Exchange Membranes , 1999 .

[27]  I. Andersson,et al.  Virucidal Treatment of Blood Protein Products with UVC Radiation , 1997, Photochemistry and photobiology.

[28]  J. Boose,et al.  Retrovirus and Parvovirus Clearance from an Affinity Column Product Using Adsorptive Depth Filtration , 2002 .

[29]  Oscar-Werner Reif,et al.  Densonucleosis virus purification by ion exchange membranes. , 2004, Biotechnology and bioengineering.

[30]  R L Fahrner,et al.  Membrane ion-exchange chromatography for process-scale antibody purification. , 2001, Journal of chromatography. A.

[31]  Joe X. Zhou,et al.  Viral clearance using disposable systems in monoclonal antibody commercial downstream processing , 2008, Biotechnology and bioengineering.

[32]  S. Williams,et al.  Presence and transcription of intracisternal A-particle-related sequences in CHO cells , 1990, Journal of virology.

[33]  Kyoichi Saito,et al.  Comparison of Two Convection‐Aided Protein Adsorption Methods Using Porous Membranes and Perfusion Beads , 1996 .

[34]  Uwe Gottschalk,et al.  New Q membrane scale-down model for process-scale antibody purification. , 2006, Journal of chromatography. A.

[35]  P. Shabram,et al.  Scalability of a Disposable Bioreactor from 25 L-500 L Run in Perfusion Mode with a CHO-Based Cell Line: A Tech Review , 2004 .

[36]  C. Peacock,et al.  Sorption of aqueous heavy metals by mineral surfaces: Insights from quantum chemistry, spectroscopy and surface complexation modeling (abstract of paper presented at 229th American Chemical Society National Meeting, San Diego, USA, March 13-17, 2005) , 2005 .

[37]  D. Frey,et al.  Dispersion in stacked-membrane chromatography , 1992 .

[38]  Tim Tressel,et al.  Current Therapeutic Antibody Production and Process Optimization , 2006 .

[39]  S. Nochumson,et al.  Large‐scale capture and partial purification of plasmid DNA using anion‐exchange membrane capsules , 2003, Biotechnology and applied biochemistry.

[40]  M. Meys,et al.  Antibody quantitation in seconds using affinity Perfusion Chromatography. , 1991, BioTechniques.

[41]  S L Morrison,et al.  Effect of glycosylation on antibody function: implications for genetic engineering. , 1997, Trends in biotechnology.

[42]  B. L. Thomas,et al.  Adsorptive membrane chromatography for purification of plasmid DNA. , 2003, Journal of chromatography. A.

[43]  G. Walsh.  Biopharmaceuticals : Approvals and addroval trends in 2004 , 2005 .

[44]  M Vanderlaan,et al.  Performance comparison of Protein A affinity‐chromatography sorbents for purifying recombinant monoclonal antibodies , 1999, Biotechnology and applied biochemistry.

[45]  A. Daemmrich,et al.  PHARMA SINCE 1870: A RISING DRUG INDUSTRYThe pharmaceutical industry since 1870 has become gargantuan, but consumers cling to a love-hate relationship with drugs for health , 2005 .

[46]  K. Reid,et al.  Inactivation of Viruses during Ultraviolet Light Treatment of Human Intravenous Immunoglobulin and Albumin , 1993, Vox sanguinis.

[47]  D K Robinson,et al.  Industrial choices for protein production by large-scale cell culture. , 2001, Current opinion in biotechnology.

[48]  M. Shields,et al.  Plasmid purification using membrane-based anion-exchange chromatography. , 2001, Analytical biochemistry.

[49]  F B Anspach,et al.  Endotoxin removal from protein solutions. , 2000, Journal of biotechnology.

[50]  R. Werner,et al.  Economic aspects of commercial manufacture of biopharmaceuticals. , 2004, Journal of biotechnology.

[51]  M. Stephan,et al.  Total organic carbon measurement as a substitute for the USP oxidizable substances test. , 1991, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

[52]  T. Root,et al.  Refining the description of protein chromatography , 1997 .

[53]  Marcel Kuiper,et al.  Purification of a functional gene therapy vector derived from Moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography , 2002, Biotechnology and bioengineering.

[54]  R. Jefferis.  Glycosylation of Recombinant Antibody Therapeutics , 2008, Biotechnology progress.

[55]  Paul W. Sauer,et al.  A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies. , 2000, Biotechnology and bioengineering.

[56]  A. Darling,et al.  Validation of biopharmaceutical purification processes for virus clearance evaluation , 2002, Molecular biotechnology.

[57]  M. Butler,et al.  Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. , 1998, Journal of biotechnology.

[58]  Joe X. Zhou,et al.  pH-conductivity hybrid gradient cation-exchange chromatography for process-scale monoclonal antibody purification. , 2007, Journal of chromatography. A.

[59]  Raja Ghosh,et al.  Protein separation using membrane chromatography: opportunities and challenges. , 2002, Journal of chromatography. A.

[60]  N. Afeyan,et al.  Large–Scale Processing & High–Throughput Perfusion Chromatography , 1992, Bio/Technology.

[61]  M. Luther,et al.  Rapid, two-step purification process for the preparation of pyrogen-free murine immunoglobulin G1 monoclonal antibodies. , 1992, Journal of chromatography.

[62]  Glenwyn D. Kemp,et al.  Large-Scale Production of Therapeutic Antibodies: Considerations for Optimizing Product Capture and Purification , 2004 .

[63]  J. Hotta,et al.  Virus inactivation and protein recovery in a novel ultraviolet‐C reactor , 2004, Vox sanguinis.

[64]  Catherine Charcosset,et al.  Review: Purification of proteins by membrane chromatography , 1998 .

[65]  M Vanderlaan,et al.  Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes , 2001, Biotechnology & genetic engineering reviews.